Literature DB >> 11999170

Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.

Adam Elhofy1, Kevin J Kennedy, Brian T Fife, William J Karpus.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a T cell mediated demyelinating disease of the central nervous system (CNS) that serves as a model for multiple sclerosis (MS). Insights into the pathogenesis of this model may help scientists understand the human disease and aid in rational drug discovery. In this review we summarize the role of chemokines and chemokine receptors in disease pathogenesis and suggest a pathway of events that leads to demyelination and subsequent clinical disease manifestation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999170     DOI: 10.1385/IR:25:2:167

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  44 in total

Review 1.  Is MS an auto-immune disease or a chronic gammaherpesvirus infection?

Authors:  H S MacGregor; Q I Latiwonk
Journal:  J Clin Lab Immunol       Date:  1996

2.  Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.

Authors:  Y Jiang; M N Salafranca; S Adhikari; Y Xia; L Feng; M K Sonntag; C M deFiebre; N A Pennell; W J Streit; J K Harrison
Journal:  J Neuroimmunol       Date:  1998-06-01       Impact factor: 3.478

3.  Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis.

Authors:  A R Glabinski; M Krakowski; Y Han; T Owens; R M Ransohoff
Journal:  J Neurovirol       Date:  1999-02       Impact factor: 2.643

Review 4.  Chemokine receptor antagonism as a new therapy for multiple sclerosis.

Authors:  R M Ransohoff; K B Bacon
Journal:  Expert Opin Investig Drugs       Date:  2000-05       Impact factor: 6.206

5.  Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent.

Authors:  J B Rottman; A J Slavin; R Silva; H L Weiner; C G Gerard; W W Hancock
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

6.  Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.

Authors:  J Hesselgesser; H P Ng; M Liang; W Zheng; K May; J G Bauman; S Monahan; I Islam; G P Wei; A Ghannam; D D Taub; M Rosser; R M Snider; M M Morrissey; H D Perez; R Horuk
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

7.  Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis.

Authors:  R M Ransohoff; T A Hamilton; M Tani; M H Stoler; H E Shick; J A Major; M L Estes; D M Thomas; V K Tuohy
Journal:  FASEB J       Date:  1993-04-01       Impact factor: 5.191

8.  Chemokine expression in murine experimental allergic encephalomyelitis.

Authors:  R Godiska; D Chantry; G N Dietsch; P W Gray
Journal:  J Neuroimmunol       Date:  1995-05       Impact factor: 3.478

9.  CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.

Authors:  B T Fife; G B Huffnagle; W A Kuziel; W J Karpus
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  6 in total

1.  Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.

Authors:  Max Eberle; Philipp Ebel; Christoph A Mayer; Julia Barthelmes; Nadja Tafferner; Nerea Ferreiros; Thomas Ulshöfer; Marina Henke; Christian Foerch; Anika Männer de Bazo; Sabine Grösch; Gerd Geisslinger; Klaus Willecke; Susanne Schiffmann
Journal:  Immunol Cell Biol       Date:  2015-04-02       Impact factor: 5.126

2.  Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.

Authors:  Laura Piccio; Jennifer L Stark; Anne H Cross
Journal:  J Leukoc Biol       Date:  2008-08-04       Impact factor: 4.962

3.  Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis.

Authors:  Silvia Pastor; Alfredo Minguela; Wentao Mi; E Sally Ward
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

4.  Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.

Authors:  Adi Vaknin-Dembinsky; Gopal Murugaiyan; David A Hafler; Anne L Astier; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2008-04-10       Impact factor: 3.478

5.  Involvement of beta-chemokines in the development of inflammatory demyelination.

Authors:  Ileana Banisor; Thomas P Leist; Bernadette Kalman
Journal:  J Neuroinflammation       Date:  2005-02-24       Impact factor: 8.322

6.  Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.

Authors:  Xin Li; Tian-Tian Li; Xiao-Hui Zhang; Li-Fei Hou; Xiao-Qian Yang; Feng-Hua Zhu; Wei Tang; Jian-Ping Zuo
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.